Parole chiave di "The cyclin-dependent kinase inhibitor PHA-848125 suppresses the in vitro growth of human melanomas sensitive or resistant to temozolomide, and shows synergistic effects in combination with this triazene compound"

Label

• Parole chiave di "The cyclin-dependent kinase inhibitor PHA-848125 suppresses the in vitro growth of human melanomas sensitive or resistant to temozolomide, and shows synergistic effects in combination with this triazene compound" (literal)
• Keywords of "The cyclin-dependent kinase inhibitor PHA-848125 suppresses the in vitro growth of human melanomas sensitive or resistant to temozolomide, and shows synergistic effects in combination with this triazene compound" (literal)

Insieme di parole chiave di

• The cyclin-dependent kinase inhibitor PHA-848125 suppresses the in vitro growth of human melanomas sensitive or resistant to temozolomide, and shows synergistic effects in combination with this triazene compound (Articolo in rivista) (Prodotto della ricerca)

Ha membro

• Melanoma (Parola chiave)
• Cell growth (Parola chiave)
• Temozolomide (Parola chiave)
• Cyclin-dependent kinase inhibitor (Parola chiave)
• Cell cycle (Parola chiave)

Incoming links:

Insieme di parole chiave

• The cyclin-dependent kinase inhibitor PHA-848125 suppresses the in vitro growth of human melanomas sensitive or resistant to temozolomide, and shows synergistic effects in combination with this triazene compound (Articolo in rivista) (Prodotto della ricerca)

Membro di

• Melanoma (Parola chiave)
• Cell cycle (Parola chiave)
• Cell growth (Parola chiave)
• Temozolomide (Parola chiave)
• Cyclin-dependent kinase inhibitor (Parola chiave)